MedTrace Logo

AM-101 in the Treatment of Post-Acute Tinnitus 1

NCT01934010 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 260

Last updated 2018-05-16

Study results available
· View outcomes & findings →

Summary

The purpose of this research study is to test the safety and local tolerance of repeated treatment cycles of AM-101.

Conditions

  • Tinnitus

Interventions

DRUG

AM-101

AM-101 gel for intratympanic injection

Sponsors & Collaborators

  • Auris Medical, Inc.

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
76 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-06-30
Primary Completion
2017-01-31
Completion
2017-01-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01934010 on ClinicalTrials.gov